セグメント別営業概況 | 業績・財務 | 宝ホールディングス株式会社
https://ir.takara.co.jp/ja/Finance/BusinessArea.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
External timestamp
The evidence pack includes the third-party timestamp files.
セグメント別営業概況 | 業績・財務 | 宝ホールディングス株式会社
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page reports Takara Holdings Inc.'s business segment overview for the fiscal year ending March 2025. Consolidated net sales reached 362,693 million yen (up 6.9% YoY), while operating profit was 20,597 million yen (down 7.4%). Takara Shuzo (32.99%) saw declines in spirits and sake but growth in seasonings. Takara Shuzo International Group (51.23%) achieved 185,803 million yen in sales (up 15.8%) through overseas alcohol and Japanese food distribution businesses. Takara Bio Group (12.42%) operates in biotech reagents, equipment manufacturing, and CDMO services for gene therapy development.
